Nigel Rawson
: Senior Fellow
Expert Overview
Dr. Nigel Rawson is a pharmacoepidemiologist and pharmaceutical policy researcher based in Saskatoon. He is also a senior fellow with the Fraser Institute.
He has performed epidemiologic studies of the use of drugs and their outcomes for over 40 years and published more than 170 chapters and articles in peer-reviewed journals and a monograph on drug safety. He has also given numerous invited presentations in many countries.
He holds an MSc in Statistics and a PhD in Pharmacoepidemiology. He held academic research positions in the Universities of London and Southampton in the United Kingdom until the end of 1989, when he became a research scientist at the University of Saskatchewan and later Merck Frosst/MRC Research Professor of Pharmacoepidemiology. He was subsequently professor of Pharmacoepidemiology at Memorial University of Newfoundland. His research activities in Canada focused on population-based studies of the use and safety of drugs using administrative healthcare utilization data and the evaluation of issues impacting Canadians’ access to new medicines.
He has also been a senior researcher in an independent research centre in one of the United States’ largest health insurance companies, where he collaborated with the Food and Drug Administration on drug safety studies, and is GlaxoSmithKline’s only epidemiologist in Canada providing advice and analysis for the company’s existing and developing medicines and vaccines.
Nigel Rawson's work for MLI
